King of Prussia, PA—28-October 2011 – Theorem Clinical Research, previously Omnicare Clinical Research, announced today that Adam Serody has joined the company as Vice President, Global Business Development. In his new role, Adam will lead Theorem’s Global Sales, Proposals and Marketing organizations.
“Throughout his career, Adam has achieved significant operational, as well as business development successes,” said John Potthoff, PhD, President and CEO of Theorem. “His clinical background, proven sales track record, and expertise in driving Marketing and Proposals efforts provide Adam with a unique perspective on every aspect of not only the sales cycle, but also the clinical development cycle. With Adam leading our team, I believe we will be uniquely positioned for future success.”
Most recently, Adam served as Executive Director of Business Development and Global Leader for Phase IV at Pharmanet. Over the last 15 years, he has held positions overseeing Sales, Proposals and Clinical Operations at various organizations including Dimensional HealthCare and Paragon Biomedical. He began his career in academia researching neurodegenerative disorders, with an emphasis in Alzheimer’s and Huntingdon’s disease.
Adam holds a Bachelor’s Degree in Experimental Psychology from the California State University, and earned a certification in Clinical Research and Data Management from Mercer College. He has been quoted in several industry publications, as well as presented at industry conferences.
About Theorem Clinical Research (previously Omnicare Clinical Research)
Established in 1985, Theorem Clinical Research is a leading global, full-service contract research organization (CRO) headquartered in King of Prussia, Pennsylvania. With office locations in 32 countries, the mid-sized firm has relationships with customers all across the globe comprised of some of the world’s leading pharmaceutical, biotechnology and medical device companies. Theorem is specialized in medical device and technical services with pharmaceutical development (Phase I-IV) focused on proactive project management and fast to first-patient-in. For more information on Theorem, visit: www.TheoremClinical.com
